Sartorius
David Kent is a Partnerships Manager at Sartorius Stedim Biotech since May 2023 and previously held roles in various organizations, including Senior Research Associate in Process Development at Fate Therapeutics Inc. from February 2022 to March 2023, and Cell Therapy Manufacturing Associate IV at NKGen Biotech, Inc. from March 2021 to February 2022. Kent's experience includes internships and consulting roles related to bioprocessing and cell therapy, as well as instruction in figure skating. Kent holds a Master of Engineering in Biopharmaceutical Processing from Keck Graduate Institute and a Bachelor of Science in Biotechnology with a minor in Chemistry from California State Polytechnic University-Pomona. Currently a PhD candidate in Applied Sciences at Keck Graduate Institute, Kent has a strong foundation in bioprocessing, cell culture techniques, and project management, complemented by a background in mentorship and team collaboration.
This person is not in the org chart
This person is not in any offices
Sartorius
20 followers
Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company's customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The Company operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.